熱門資訊> 正文
AcelRx Pharmaceuticals 2024年第一季度盈利预览
2024-05-14 05:20
- AcelRx Pharmaceuticals (NASDAQ:TLPH) is scheduled to announce Q1 earnings results on Tuesday, May 14th, after market close.
- The consensus EPS Estimate is -$0.21.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward.
More on AcelRx Pharmaceuticals
- Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals
- Historical earnings data for AcelRx Pharmaceuticals
- Financial information for AcelRx Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
